- Home
- CAC vs ARCT Comparison
CAC vs ARCT Comparison
Compare CAC & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAC
- ARCT
- Stock Information
- Founded
- CAC 1875
- ARCT 2013
- Country
- CAC United States
- ARCT United States
- Employees
- CAC N/A
- ARCT N/A
- Industry
- CAC Major Banks
- ARCT Biotechnology: Pharmaceutical Preparations
- Sector
- CAC Finance
- ARCT Health Care
- Exchange
- CAC Nasdaq
- ARCT Nasdaq
- Market Cap
- CAC N/A
- ARCT 487.0M
- IPO Year
- CAC 1997
- ARCT N/A
- Fundamental
- Price
- CAC $43.80
- ARCT $17.12
- Analyst Decision
- CAC Hold
- ARCT Strong Buy
- Analyst Count
- CAC 3
- ARCT 7
- Target Price
- CAC $46.67
- ARCT $65.00
- AVG Volume (30 Days)
- CAC 75.8K
- ARCT 348.5K
- Earning Date
- CAC 01-28-2025
- ARCT 03-06-2025
- Dividend Yield
- CAC 3.83%
- ARCT N/A
- EPS Growth
- CAC N/A
- ARCT N/A
- EPS
- CAC 3.20
- ARCT N/A
- Revenue
- CAC $168,756,000.00
- ARCT $160,399,000.00
- Revenue This Year
- CAC N/A
- ARCT $7.33
- Revenue Next Year
- CAC $30.91
- ARCT $4.71
- P/E Ratio
- CAC $13.70
- ARCT N/A
- Revenue Growth
- CAC N/A
- ARCT N/A
- 52 Week Low
- CAC $28.62
- ARCT $14.30
- 52 Week High
- CAC $50.07
- ARCT $45.00
- Technical
- Relative Strength Index (RSI)
- CAC 51.07
- ARCT 48.75
- Support Level
- CAC $43.09
- ARCT $15.82
- Resistance Level
- CAC $45.29
- ARCT $17.93
- Average True Range (ATR)
- CAC 1.01
- ARCT 1.51
- MACD
- CAC 0.25
- ARCT -0.04
- Stochastic Oscillator
- CAC 69.72
- ARCT 23.90
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19.